Alps Advisors Inc Selecta Biosciences Inc Transaction History

Alps Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.89 - $4.43 $407,634 - $624,851	-141,050 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $27,014 - $37,144	-8,040 Reduced 5.39%	141,050 $587,000
Q2 2021 Aug 11, 2021	SELL	$2.82 - $5.01 $130,732 - $232,258	-46,359 Reduced 23.72%	149,090 $623,000
Q1 2021 May 07, 2021	BUY	$2.92 - $5.07 $10,538 - $18,297	3,609 Added 1.88%	195,449 $884,000
Q4 2020 Feb 03, 2021	BUY	$1.64 - $3.42 $274,025 - $571,444	167,089 Added 675.08%	191,840 $581,000
Q2 2018 Jul 25, 2018	SELL	$9.36 - $13.25 $48,737 - $68,992	-5,207 Reduced 17.38%	24,751 $243,000
Q1 2018 May 01, 2018	BUY	$8.49 - $11.82 $44,207 - $61,546	5,207 Added 21.04%	29,958 $305,000
Q4 2017 Feb 05, 2018	BUY	$8.97 - $23.38 $222,016 - $578,678	24,751	24,751 $243,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.